IDYA · ISSUER CIK 1676725
IDEAYA Biosciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 IDEAYA Biosciences, Inc. insiders reported $0.00 of open-market purchases and $985K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$985KInsider selling
−$985KNet open-market
Oct 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202619:03 | Oct 6, 2026 | IDYA | President and CEO, Director | S · Sell10b5-1 | $37.41 | −26,338 | 690,695 | -4% | −$985K | ||
| Oct 8, 202619:03 | Oct 6, 2026 | IDYA | President and CEO, Director | M · Exercise10b5-1 | $4.31 | +26,338 | 717,033 | +4% | $114K |